Viking Therapeutics (VKTX) Short Interest Ratio & Short Volume $51.53 +0.02 (+0.04%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Viking Therapeutics Short Interest DataViking Therapeutics (VKTX) has a short interest of 13.28 million shares. This marks a -7.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.4, indicating that it would take 3.4 days of the average trading volume of 4.55 million shares to cover all short positions.Current Short Interest13,280,000 sharesPrevious Short Interest14,390,000 sharesChange Vs. Previous Month-7.71%Dollar Volume Sold Short$963.33 millionShort Interest Ratio3.4 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares111,440,000 sharesPercentage of Shares Shorted11.92%Today's Trading Volume3,496,787 sharesAverage Trading Volume4,548,423 sharesToday's Volume Vs. Average77% Short Selling Viking Therapeutics? Sign up to receive the latest short interest report for Viking Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVKTX Short Interest Over TimeVKTX Days to Cover Over TimeVKTX Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Viking Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202413,280,000 shares $963.33 million -7.7%N/A3.4 $72.54 10/15/202414,390,000 shares $940.82 million -0.6%N/A4 $65.38 9/30/202414,480,000 shares $916.73 million -9.0%N/A4.1 $63.31 9/15/202415,910,000 shares $1.06 billion -7.2%N/A4.1 $66.73 8/31/202417,140,000 shares $1.10 billion -3.2%N/A4.5 $64.12 8/15/202417,700,000 shares $1.01 billion +5.0%N/A4.6 $57.00 Get the Latest News and Ratings for VKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202416,860,000 shares $961.02 million +11.7%N/A4.3 $57.00 7/15/202415,100,000 shares $896.64 million -10.3%N/A4.4 $59.38 6/30/202416,830,000 shares $892.16 million +32.8%N/A5 $53.01 6/15/202412,670,000 shares $659.09 million +2.9%N/A3.6 $52.02 5/31/202412,310,000 shares $766.42 million +1.2%N/A3.2 $62.26 5/15/202412,170,000 shares $949.38 million +0.5%N/A2 $78.01 4/30/202412,110,000 shares $963.71 million +8.6%N/A1.9 $79.58 4/15/202411,150,000 shares $746.49 million +17.1%N/A1.8 $66.95 3/31/20249,520,000 shares $780.64 million -14.5%N/A1.5 $82.00 3/15/202411,140,000 shares $696.92 million -9.3%N/A1.8 $62.56 2/29/202412,280,000 shares $946.17 million +2.2%N/A2.2 $77.05 2/15/202412,020,000 shares $382.84 million -7.0%N/A3 $31.85 1/31/202412,920,000 shares $311.89 million -5.8%N/A4.6 $24.14 1/15/202413,710,000 shares $293.94 million +1.9%N/A5.3 $21.44 12/31/202313,460,000 shares $250.49 million -7.8%N/A5.3 $18.61 12/15/202314,600,000 shares $275.94 million -5.3%N/A5.9 $18.90 11/30/202315,420,000 shares $188.43 million -9.1%N/A6.4 $12.22 11/15/202316,970,000 shares $187.18 million +3.4%N/A8.5 $11.03 10/31/202316,420,000 shares $161.08 million +11.0%N/A8.6 $9.81 10/15/202314,800,000 shares $162.06 million +6.6%N/A7.7 $10.95 9/30/202313,890,000 shares $153.76 million +1.8%N/A7.8 $11.07 9/15/202313,640,000 shares $201.46 million +5.7%N/A6.6 $14.77 8/31/202312,910,000 shares $178.29 million -5.0%N/A5.6 $13.81 8/15/202313,590,000 shares $201.27 million +14.8%N/A5.5 $14.81 7/31/202311,840,000 shares $171.68 million -2.7%N/A4.2 $14.50 7/15/202312,170,000 shares $189.61 million +0.7%N/A4 $15.58 6/30/202312,090,000 shares $195.98 million +9.2%N/A3.6 $16.21 6/15/202311,070,000 shares $248.63 million -6.9%N/A2.2 $22.46 5/31/202311,890,000 shares $261.10 million -1.2%N/A2.5 $21.96 5/15/202312,030,000 shares $264.54 million +3.8%N/A2.5 $21.99 4/30/202311,590,000 shares $246.98 million +1.3%N/A2.6 $21.31 4/15/202311,440,000 shares $214.50 million +1.6%N/A2.7 $18.75 3/31/202311,260,000 shares $187.48 million +112.1%N/A2.9 $16.65 3/15/20235,310,000 shares $56.71 million +9.5%7.8%1.8 $10.68Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 2/28/20234,850,000 shares $53.40 million +4.1%7.1%1.3 $11.01 2/15/20234,660,000 shares $51.91 million +17.7%6.9%1.3 $11.14 1/31/20233,960,000 shares $34.69 million -33.2%5.9%1.1 $8.76 1/15/20235,930,000 shares $53.07 million +4.2%8.9%1.7 $8.95 12/30/20225,690,000 shares $53.49 million +201.1%8.4%1.7 $9.40 12/15/20221,890,000 shares $7.28 million +6.8%2.8%0.6 $3.85 11/30/20221,770,000 shares $7.17 million -1.7%2.6%2.3 $4.05 11/15/20221,800,000 shares $8.05 million -5.3%2.7%2.4 $4.47 10/31/20221,900,000 shares $7.79 million +6.2%2.8%2.9 $4.10 10/15/20221,790,000 shares $5.85 million -4.8%2.7%2.6 $3.27 9/30/20221,880,000 shares $5.11 million -2.6%2.8%3 $2.72 9/15/20221,930,000 shares $6.41 million -4.5%2.8%2.2 $3.32 8/31/20222,020,000 shares $6.42 million -3.4%3.0%2.1 $3.18 8/15/20222,090,000 shares $8.13 million -3.7%3.1%1.9 $3.89 7/31/20222,170,000 shares $0.00 -11.4%3.2%1.9 $0.00 7/15/20222,450,000 shares $9.07 million -9.6%3.6%2.2 $3.70 6/30/20222,710,000 shares $7.83 million -41.1%3.9%2.4 $2.89 6/15/20224,600,000 shares $9.98 million -1.9%6.7%4.4 $2.17 5/31/20224,690,000 shares $10.41 million +4.5%6.8%4.9 $2.22 5/15/20224,490,000 shares $10.46 million +16.3%6.5%4.8 $2.33 4/30/20223,860,000 shares $9.19 million +4.3%5.6%3.9 $2.38 4/15/20223,700,000 shares $10.21 million +3.9%5.4%3.4 $2.76 3/31/20223,560,000 shares $10.68 million -20.2%5.1%3.2 $3.00 3/15/20224,460,000 shares $13.51 million +2.5%6.4%3.9 $3.03 2/28/20224,350,000 shares $14.57 million +4.8%6.2%4.1 $3.35 2/15/20224,150,000 shares $15.69 million -4.2%5.9%3.8 $3.78 1/31/20224,330,000 shares $16.06 million +19.0%6.2%4.5 $3.71 1/15/20223,640,000 shares $15.43 million -0.6%5.2%4 $4.24 12/31/20213,660,000 shares $16.84 million -12.0%5.3%5.1 $4.60 12/15/20214,160,000 shares $20.09 million -15.8%5.9%6.1 $4.83 11/30/20214,940,000 shares $26.23 million +3.4%7.0%8 $5.31 11/15/20214,780,000 shares $28.73 million -4.0%6.8%7.7 $6.01 10/29/20214,980,000 shares $28.98 million +4.8%7.1%8 $5.82 10/15/20214,750,000 shares $28.55 million -6.3%6.8%7.8 $6.01 9/30/20215,070,000 shares $31.84 million -13.5%7.2%8 $6.28 9/15/20215,860,000 shares $38.03 million -8.0%8.3%8.4 $6.49 8/31/20216,370,000 shares $42.11 million -13.7%9.1%7.9 $6.61 8/13/20217,380,000 shares $43.62 million -9.0%10.5%8.4 $5.91 7/30/20218,110,000 shares $49.88 million +2.8%11.6%9 $6.15 7/15/20217,890,000 shares $46.08 million -3.1%11.3%8.4 $5.84 6/30/20218,140,000 shares $48.76 million -17.8%11.6%8.3 $5.99 6/15/20219,900,000 shares $59.70 million -2.5%14.1%10.1 $6.03 5/28/202110,150,000 shares $53.19 million -5.8%14.5%11 $5.24 5/14/202110,770,000 shares $63.76 million +1.7%15.4%11.2 $5.92 4/30/202110,590,000 shares $66.29 million -4.6%15.2%9.5 $6.26 4/15/202111,100,000 shares $66.60 million +10.5%16.1%8.2 $6.00 3/31/202110,050,000 shares $60.90 million +18.0%15.5%7.1 $6.06 3/15/20218,520,000 shares $57.51 million +1.2%13.1%5.6 $6.75 2/26/20218,420,000 shares $57.93 million +1.7%13.0%5.5 $6.88 2/12/20218,280,000 shares $72.12 million -2.2%12.7%5.4 $8.71Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 1/29/20218,470,000 shares $63.69 million -3.5%13.1%5.8 $7.52 1/15/20218,780,000 shares $58.47 million -3.3%13.6%6.7 $6.66 12/31/20209,080,000 shares $53.03 million +3.1%14.0%7.4 $5.84 12/15/20208,810,000 shares $59.12 million -11.6%13.5%7.6 $6.71 11/30/20209,960,000 shares $66.53 million -7.0%15.3%8.4 $6.68 10/30/202010,140,000 shares $56.58 million -2.5%15.6%8.4 $5.58 10/15/202010,400,000 shares $60.89 million -7.1%16.0%8.5 $5.86 9/30/202011,200,000 shares $65.18 million +19.9%17.3%8.9 $5.82 9/15/20209,340,000 shares $58.38 million +7.1%14.4%7.1 $6.25 8/31/20208,720,000 shares $58.34 million -0.1%13.4%6.6 $6.69 8/14/20208,730,000 shares $64.25 million -17.6%12.3%6.5 $7.36 7/31/202010,590,000 shares $74.34 million +6.3%14.9%7.2 $7.02 7/15/20209,960,000 shares $68.23 million -16.4%14.1%6.4 $6.85 6/30/202011,920,000 shares $85.94 million +8.6%16.9%7.3 $7.21 6/15/202010,980,000 shares $82.57 million -2.1%15.5%6.7 $7.52 5/29/202011,210,000 shares $80.15 million -8.5%15.9%6.5 $7.15 5/15/202012,250,000 shares $86.98 million -1.5%17.3%7 $7.10 4/30/202012,440,000 shares $71.65 million -8.7%17.6%7.8 $5.76 4/15/202013,620,000 shares $71.78 million -7.7%19.3%9.3 $5.27 3/31/202014,760,000 shares $69.08 million +0.1%20.9%10.8 $4.68 3/13/202014,749,400 shares $74.48 million -11.5%23.3%10.4 $5.05 2/28/202016,660,000 shares $67.47 million +11.1%26.3%14.5 $4.05 2/14/202014,990,000 shares $83.94 million -2.8%23.4%13.1 $5.60 1/31/202015,420,000 shares $96.07 million -6.1%24.0%12.5 $6.23 1/15/202016,420,000 shares $109.69 million +10.2%25.6%12.2 $6.68 12/31/201914,900,000 shares $98.19 million -5.8%23.2%11.6 $6.59 VKTX Short Interest - Frequently Asked Questions What is Viking Therapeutics' current short interest? Short interest is the volume of Viking Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 13,280,000 shares of VKTX short. Learn More on Viking Therapeutics' current short interest. What is a good short interest ratio for Viking Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VKTX shares currently have a short interest ratio of 3.0. Learn More on Viking Therapeutics's short interest ratio. Which institutional investors are shorting Viking Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Viking Therapeutics: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, Mirae Asset Securities USA Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Viking Therapeutics' short interest increasing or decreasing? Viking Therapeutics saw a decrease in short interest in October. As of October 31st, there was short interest totaling 13,280,000 shares, a decrease of 7.7% from the previous total of 14,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Viking Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Viking Therapeutics: Prothena Co. plc (13.99%), Puma Biotechnology, Inc. (9.07%), Marinus Pharmaceuticals, Inc. (10.26%), Teva Pharmaceutical Industries Limited (1.60%), BeiGene, Ltd. (1.12%), Viatris Inc. (2.09%), Summit Therapeutics Inc. (2.31%), Moderna, Inc. (10.02%), Genmab A/S (0.37%), Dr. Reddy's Laboratories Limited (1.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Viking Therapeutics stock? Short selling VKTX is an investing strategy that aims to generate trading profit from Viking Therapeutics as its price is falling. VKTX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Viking Therapeutics? A short squeeze for Viking Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VKTX, which in turn drives the price of the stock up even further. How often is Viking Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VKTX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Prothena Short Squeeze Puma Biotechnology Short Squeeze Marinus Pharmaceuticals Short Squeeze Teva Pharmaceutical Industries Short Squeeze BeiGene Short Squeeze Viatris Short Squeeze Summit Therapeutics Short Squeeze Moderna Short Squeeze Genmab A/S Short Squeeze Dr. Reddy's Laboratories Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VKTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
